128 related articles for article (PubMed ID: 10511466)
1. Prohormone convertase-1 is essential for conversion of chromogranin A to pancreastatin.
Udupi V; Lee HM; Kurosky A; Greeley GH
Regul Pept; 1999 Sep; 83(2-3):123-7. PubMed ID: 10511466
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of prohormone convertase-1 by a phorbol ester.
Udupi V; Townsend CM; Gomez G; Zhang T; Greeley GH
Biochem Biophys Res Commun; 1995 Dec; 217(2):495-500. PubMed ID: 7503727
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries.
Lloyd RV; Jin L; Qian X; Scheithauer BW; Young WF; Davis DH
Am J Pathol; 1995 May; 146(5):1188-98. PubMed ID: 7747813
[TBL] [Abstract][Full Text] [Related]
4. Production and secretion of chromogranin A and pancreastatin by the human pancreatic carcinoma cell line QGP-1N on stimulation with carbachol.
Kitayama N; Tateishi K; Funakoshi A; Kono A; Matsuoka Y
Regul Pept; 1994 Aug; 52(3):195-203. PubMed ID: 7800852
[TBL] [Abstract][Full Text] [Related]
5. Distribution and regulation of proconvertases PC1 and PC2 in human pituitary adenomas.
Jin L; Kulig E; Qian X; Scheithauer BW; Young WF; Davis DH; Seidah NG; Chretien M; Lloyd RV
Pituitary; 1999 May; 1(3-4):187-95. PubMed ID: 11081197
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pancreastatin release from a human pancreatic carcinoid cell line in vitro.
Jeng YJ; Townsend CM; Nagasawa S; Chuo S; Kern K; Yanaihara N; Ferrar RS; Hill FL; Thompson JC; Greeley GH
Endocrinology; 1991 Jan; 128(1):220-5. PubMed ID: 1702700
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester-induced alteration in the pattern of secretion and storage of chromogranin A and neurotensin in a human pancreatic carcinoid cell line.
Zhang T; Townsend CM; Udupi V; Yanaihara N; Rajaraman S; Beauchamp RD; Ishizuka J; Evers BM; Gomez G; Thompson JC
Endocrinology; 1995 May; 136(5):2252-61. PubMed ID: 7720675
[TBL] [Abstract][Full Text] [Related]
8. A phylogenetic survey of pancreastatin and chromogranin immunoreactivity in chromaffin (TH-, DBH-, and PNMT-immunoreactive) cells of the adrenal organ of vertebrates.
Reinecke M; Maake C
Gen Comp Endocrinol; 1993 May; 90(2):251-65. PubMed ID: 8100544
[TBL] [Abstract][Full Text] [Related]
9. The immunomodulatory functions of chromogranin A-derived peptide pancreastatin.
Ioannidis M; Mahata SK; van den Bogaart G
Peptides; 2022 Dec; 158():170893. PubMed ID: 36244579
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of prohormone convertase-1 mRNA expression by second messenger signaling systems.
Udupi V; Townsend CM; Greeley GH
Biochem Biophys Res Commun; 1998 May; 246(2):463-5. PubMed ID: 9610384
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic processing of chromogranin A by the prohormone convertase PC2.
Doblinger A; Becker A; Seidah NG; Laslop A
Regul Pept; 2003 Mar; 111(1-3):111-6. PubMed ID: 12609757
[TBL] [Abstract][Full Text] [Related]
12. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases.
Pilichowska M; Kimura N; Ouchi A; Lin H; Mizuno Y; Nagura H
Pathol Int; 1999 Apr; 49(4):318-24. PubMed ID: 10365851
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors.
Kimura N; Pilichowska M; Okamoto H; Kimura I; Aunis D
Mod Pathol; 2000 Feb; 13(2):140-6. PubMed ID: 10697270
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.
Eskeland NL; Zhou A; Dinh TQ; Wu H; Parmer RJ; Mains RE; O'Connor DT
J Clin Invest; 1996 Jul; 98(1):148-56. PubMed ID: 8690787
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical localization of prohormone convertase 1/3 and 2 in gastrointestinal carcinoids.
Tomita T
Endocr Pathol; 2001; 12(2):137-45. PubMed ID: 11579679
[TBL] [Abstract][Full Text] [Related]
16. Comparison of chromogranin A and pancreastatin levels in plasma of patients with pancreatic islet cell tumor.
Tateishi K; Kitayama N; Matsuoka Y; Funakoshi A
Life Sci; 1995; 57(9):889-95. PubMed ID: 7630318
[TBL] [Abstract][Full Text] [Related]
17. Distribution and partial characterisation of immunoreactivity to the putative C-terminus of rat pancreastatin.
Curry WJ; Johnston CF; Shaw C; Buchanan KD
Regul Pept; 1990 Oct; 30(3):207-19. PubMed ID: 2259750
[TBL] [Abstract][Full Text] [Related]
18. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia.
Syversen U; Jacobsen MB; O'Connor DT; Rønning K; Waldum HL
Neuropeptides; 1994 Mar; 26(3):201-6. PubMed ID: 8208366
[TBL] [Abstract][Full Text] [Related]
19. Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies.
Syversen U; Opsjøn SL; Stridsberg M; Sandvik AK; Dimaline R; Tingulstad S; Arntzen KJ; Brenna E; Waldum HL
J Clin Endocrinol Metab; 1996 Dec; 81(12):4470-5. PubMed ID: 8954061
[TBL] [Abstract][Full Text] [Related]
20. Comparison of plasma pancreastatin and GAWK concentrations, presumed processing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors.
Yasuda D; Iguchi H; Funakoshi A; Wakasugi H; Sekiya K; Misawa T; Tateishi K; Bloom SR; Nawata H
Horm Metab Res; 1993 Nov; 25(11):593-5. PubMed ID: 8288164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
